The extension of pre-clinical findings concerning the influence of MPC2 on mitochondrial metabolism and tumor growth27 to MPC2 gene expression and survival in women with EOC provides proof-of-concept that mitochondrial (dys)function may contribute to clinical outcomes. This evidence concerns the gene MPC2 and neoplasm.